ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,311 | +108.5% | 7,316 | +159.8% | 0.00% | – |
| Q2 2023 | $20,769 | -21.3% | 2,816 | 0.0% | 0.00% | – |
| Q1 2023 | $26,378 | -20.1% | 2,816 | -6.6% | 0.00% | – |
| Q4 2022 | $33,000 | +57.1% | 3,016 | +7.1% | 0.00% | – |
| Q3 2022 | $21,000 | +50.0% | 2,816 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | +7.7% | 2,816 | 0.0% | 0.00% | – |
| Q1 2022 | $13,000 | +8.3% | 2,816 | +55.1% | 0.00% | – |
| Q4 2021 | $12,000 | -57.1% | 1,816 | -43.5% | 0.00% | – |
| Q3 2021 | $28,000 | +40.0% | 3,212 | +23.6% | 0.00% | – |
| Q2 2021 | $20,000 | +17.6% | 2,598 | +16.9% | 0.00% | – |
| Q1 2021 | $17,000 | +88.9% | 2,223 | +78.4% | 0.00% | – |
| Q4 2020 | $9,000 | 0.0% | 1,246 | +41.4% | 0.00% | – |
| Q3 2020 | $9,000 | – | 881 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |